Ovarian function during use of Nestorone® subdermal implants
- 31 March 2000
- journal article
- Published by Elsevier in Contraception
- Vol. 61 (3) , 199-204
- https://doi.org/10.1016/s0010-7824(00)00092-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Levonorgestrel capsule implants in the United States: a 5-year studyObstetrics & Gynecology, 1998
- Ovarian Function During the Use of a Single Contraceptive Implant: Implanon Compared with NorplantFertility and Sterility, 1998
- Norplant® Consensus Statement and Background ReviewContraception, 1998
- Clinical performance of a new two-rod levonorgestrel contraceptive implant: A three-year randomized study with Norplant® implants as controlsContraception, 1997
- Ultrasonographic and endocrine evaluation of ovarian function among Norplant® implants users with regular mensesContraception, 1996
- Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraceptionInternational Journal of Gynecology & Obstetrics, 1996
- Clinical trial with Nestorone™ subdermal contraceptive implantsContraception, 1995
- Milk and plasma concentrations of the progestin ST-1435 in women treated parenterally with ST-1435Contraception, 1990
- Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435Contraception, 1982
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435Contraception, 1981